Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Company Overview

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

Key Stats

• Today's Range: $3.80 to $3.94
• 50-Day Range: $3.94 to $5.53
• 52-Week Range: $2.61 to $6.19
• Volume: 267,968 shs
• Average Volume: 375,164 shs
• Market Capitalization: $742.32 million
• P/E Ratio: 191.25
• Dividend Yield: N/A
• Price Target: $5.25
• Consensus Rating: Hold

Aveanna Healthcare Stock Analysis - MarketRank™

Aveanna Healthcare scored higher than 40% of companies evaluated by MarketBeat, and ranked 688th out of 934 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.1 / 5
• Analyst Rating: Hold

Consensus Rating

Aveanna Healthcare has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on 2 buy ratings, 3 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Aveanna Healthcare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Aveanna Healthcare is 193.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.14.

Price to Earnings Ratio vs. Sector

The P/E ratio of Aveanna Healthcare is 193.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.54.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.87% of the float of Aveanna Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Aveanna Healthcare has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Aveanna Healthcare has recently decreased by 2.44%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Aveanna Healthcare does not currently pay a dividend.

Dividend Growth

Aveanna Healthcare does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

3.87% of the float of Aveanna Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Aveanna Healthcare has a short interest ratio ("days to cover") of 4.1.

Change versus previous month

Short interest in Aveanna Healthcare has recently decreased by 2.44%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.8 / 5
• News Sentiment: 0.25

News Sentiment

Aveanna Healthcare has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Aveanna Healthcare this week, compared to 3 articles on an average week.

MarketBeat Follows

1 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $37,838,057.00 in company stock.

Percentage Held by Insiders

Only 7.80% of the stock of Aveanna Healthcare is held by insiders.

Percentage Held by Institutions

87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

AVAH Stock Analysis - Frequently Asked Questions

How have AVAH shares performed this year?

Aveanna Healthcare's stock was trading at $4.57 at the beginning of the year. Since then, AVAH stock has decreased by 15.4% and is now trading at $3.8650.

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) issued its earnings results on Thursday, November, 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. The business earned $509.02 million during the quarter, compared to the consensus estimate of $495.80 million. Aveanna Healthcare had a net margin of 0.26% and a negative trailing twelve-month return on equity of 15.16%.
Read the conference call transcript.

When did Aveanna Healthcare IPO?

Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's top institutional investors include Summit Partners L P (4.95%), Belvedere Trading LLC (0.01%), MQS Management LLC (0.01%) and Public Employees Retirement System of Ohio (0.01%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Matthew Buckhalter, Patrick A Cunningham, David Afshar, Deborah Stewart and Victor F Ganzi.
View institutional ownership trends.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Aveanna Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Voyager Therapeutics (VYGR).

Company Calendar

• Last Earnings: 11/07/2024
• Today: 8/01/2025
• Next Earnings (Estimated): 8/07/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:AVAH
• CIK: 1832332
• Web: www.aveanna.com
• Phone: 770-441-1580
• Fax: N/A
• Employees: 33,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Aveanna Healthcare: $5.25
• High Price Target: $6.00
• Low Price Target: $5.00
• Potential Upside/Downside: +38.0%
• Consensus Rating: Hold
• Rating Score (0-4): 2.17
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.02
• Trailing P/E Ratio: 191.25
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$10.93 million
• Net Margins: 0.26%
• Pretax Margin: 0.66%
• Return on Equity: -15.16%
• Return on Assets: 1.14%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.05
• Quick Ratio: 1.05

Sales & Book Value

• Annual Sales: $2.02 billion
• Price / Sales: 0.37
• Cash Flow: $0.16 per share
• Price / Cash Flow: 24.33
• Book Value: ($0.64) per share
• Price / Book: -5.95

Miscellaneous

• Outstanding Shares: 195,090,000
• Free Float: 179,877,000
• Market Cap: $742.32 million
• Optionable: Optionable
• Beta: 1.98